— Know what they know.
Not Investment Advice

ARQT NASDAQ

Arcutis Biotherapeutics, Inc.
1W: -2.6% 1M: -11.5% 3M: -17.4% YTD: -27.6% 1Y: +44.8% 3Y: +110.5% 5Y: -18.4%
$20.86
-0.15 (-0.71%)
 
Weekly Expected Move ±9.2%
$17 $19 $21 $23 $25
NASDAQ · Healthcare · Biotechnology · Alpha Radar Strong Sell · Power 36 · $2.6B mcap · 111M float · 1.41% daily turnover · Short 31% of daily vol

📊 Key Metrics

TTM
$416M
Revenue
+95.3% YoY
$-2M
Net Income
+98.2% YoY
$27M
Free Cash Flow
+123.1% YoY
90.7%
Gross Margin
-8.6%
Op. Margin
-10.7%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-1.4%
ROA-0.6%
ROIC-10.1%

Valuation

P/E-1126.1
P/B14.1
EV/EBITDA221.8

Leverage

Debt/Equity0.03
Current Ratio3.17
Interest Cov.0.7x

Quality Scores

Piotroski F6/9
Altman Z5.65
Beneish M-1.82

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms